AOD-9604 is unique in combining direct fat cell targeting through beta-3 receptor modulation with absence of systemic growth hormone effects
Once you stop having the injections, it is possible to gain weight so its vital that youre committed to a healthy lifestyle
Older testimonials may also reflect experiences with compounded GLP-1s no longer offered to new patients
First-month weight loss depends on starting dose, baseline metabolism, genetics, diet quality, and exercise
Discuss risks/benefits with the provider Medications That May Interact: Diabetes medications (insulin, sulfonylureas): Can increase the risk of hypoglycemia (low blood sugar) Dose adjustments needed Oral hormonal contraceptives (birth control pills): Tirzepatide may decrease effectiveness, especially after the first dose and dose increases Switch to a non-oral contraceptive or add a barrier method for 4 weeks after starting and after each dose increase Other GLP-1 medications: Cannot use tirzepatide with Ozempic, Wegovy, Saxenda, Victoza, Mounjaro, Zepbound, Byetta, or Bydureon Cannot combine with other weight loss medications or supplements without provider approval Mental Health Screening During the telehealth consultation, providers screen for: History of depression Suicidal thoughts or behavior Eating disorders (binge eating disorder, bulimia, and anorexia history) GLP-1 medications carry a warning about suicidal behavior and ideation
Large amounts of it are found in meat products
/assets/images/provider/photos/2736093.png)
